1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Erythromycin |
| brand | String | E.E.S., EryPed, Ery-Tab, PCE, Erythrocin (lactobionate IV); topical Erygel, Akne-Mycin; ophthalmic ointment |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Macrolide_antibiotics|Macrolide antibiotic]] • [[:Category:Antibacterials|Antibacterial]] • [[:Category:Prokinetics|Prokinetic (off-label)]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000D38-QINU`"', '"`UNIQ--vote-00000D39-QINU`"', '"`UNIQ--vote-00000D3A-QINU`"', '"`UNIQ--vote-00000D3B-QINU`"', '"`UNIQ--vote-00000D3C-QINU`"', '"`UNIQ--vote-00000D3D-QINU`"' |
| starting_dose | String | 250-500 mg PO QID; 7.5-12.5 mg/kg IV q6h; topical and ophthalmic per formulation |
| preparations | String | 250, 500 mg base or stearate tablets; ER tablets; ethyl succinate 200 mg/5 mL suspension; 500 mg, 1 g IV (lactobionate); 2% topical solution/gel; 0.5% ophthalmic ointment |
| fda_max | String | 4 g/d (rarely tolerated due to GI effects) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV • topical • ophthalmic |
| onset | String | Hours |
| duration | String | 6-8 hours |
| halflife | String | ~1.5-2 hours'"`UNIQ--ref-00000D3E-QINU`"' |
| bioavailability | String | ~30-65% (oral; acid-labile, hence enteric-coated formulations; food affects absorption variably)'"`UNIQ--ref-00000D3F-QINU`"' |
| pregnancy | String | Generally considered safe; commonly used in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC (ophthalmic ointment) and [[USLegal:Prescription only|Rx-only]] (other forms) in US |
